Capsulorhexis size and posterior capsule opacification.
OBJECTIVE
Posterior capsule opacification (PCO) after intraocular lens (IOL) implantation has a multifactored pathogenesis. Capsulorhexis and capsular bag implantation of a one-piece, biconvex poly(methyl methacrylate) (PMMA) IOL are likely to reduce the PCO incidence. This study was performed to determine whether an ideal capsulorhexis size able to reduce PCO incidence exists.


METHODS
A retrospective study of 107 patients who had extracapsular cataract extraction with capsulorhexis and capsular bag IOL implantation was carried out. The PCO site (central, paracentral, and peripheral) and degree (mild, moderate, and severe) were evaluated in relation to the capsulorhexis edge location relative to the IOL optic. Slitlamp biomicroscopy and photography and examination with a three-mirror Goldmann lens were performed. Patients were divided into three groups. Group 1: capsulorhexis free edge located on the IOL optic for 360 degrees; Group 2: capsulorhexis free edge located asymmetrically on and peripherally to the IOL optic; Group 3: capsulorhexis free edge located peripherally to IOL optic for 360 degrees. Each group was divided into two subgroups; one received polyHema IOLs and the second, PMMA IOLs.


RESULTS
In Groups 1 and 2, the capsular transparency was higher than in Group 3 (P < .04). Central opacification percentage was lower in Group 1 than in Groups 2 and 3 (P < .04). No statistically significant differences between the polyHema and the PMMA subgroups were seen.


CONCLUSIONS
Capsulorhexis with a slightly smaller diameter than the IOL optic appears to be better than a large-size capsulorhexis in reducing the incidence of PCO.
Ravalico
G
G
Istituto di Clinica Oculistica, Università di Trieste, Ospedale Maggiore, Trieste, Italy.
Tognetto
D
D
Palomba
M
M
Busatto
P
P
Baccara
F
F
D000368:Aged; D002386:Cataract / Q000473:pathology*; D002387:Cataract Extraction / Q000379:methods*; D005260:Female; D005355:Fibrosis; D005500:Follow-Up Studies; D006801:Humans; D007903:Lens Capsule, Crystalline / Q000473:pathology*; D007910:Lenses, Intraocular; D008297:Male; D008689:Methacrylates; D008768:Methylmethacrylates; D008875:Middle Aged; D011474:Prosthesis Design; D012189:Retrospective Studies
D008689:Methacrylates; D008768:Methylmethacrylates; C005044:hydroxyethyl methacrylate